Literature DB >> 14770304

Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.

Nicolas Penel1, Charles Fournier, Stéphanie Clisant, Michèle N'Guyen.   

Abstract

OBJECTIVE: The aims of our retrospective study were to study first the causes of 245 febrile episodes in cancer patients and then the value of procalcitonin (PCT) and C-reactive protein (CRP) in differentiating infections from paraneoplastic fever.
METHOD: The causes of fever were studied in 245 consecutive cases observed between January and December 2002, and PCT and CRP diagnostic value in 155 cases (114 infections and 41 paraneoplastic fever).
RESULTS: The two main causes of fever were infection (121 cases) and paraneoplastic fever (43 cases); 77 infections were microbiologically documented. Cocci gram positive caused 41 out of 77 documented infections. Paraneoplastic fever was more frequent in metastatic disease ( p=6.10(-6)). CRP and PCT serum levels at admission did not differ significantly in the infection group and paraneoplastic fever group (respectively p=0.39 and p=0.14 with Mann-Whitney test). The PCT and CRP levels had poor prognostic value in infection (respectively 0.04 and 0.0003 with Mann-Whitney test).
CONCLUSION: Causes of fever are very numerous in cancer patients (more than 75 different causes in this study). Bacterial infection is the most frequent cause. PCT and CRP failed to discriminate infection, but both had pejorative prognostic value in infected patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14770304     DOI: 10.1007/s00520-004-0602-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  25 in total

1.  Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1.

Authors:  Y Gérard; D Hober; M Assicot; S Alfandari; F Ajana; J M Bourez; C Chidiac; Y Mouton; C Bohuon; P Wattre
Journal:  J Infect       Date:  1997-07       Impact factor: 6.072

2.  Change in serum procalcitonin (deltaPCT) predicts the clinical outcome of children admitted with febrile neutropenia.

Authors:  Chris Barnes; Vera Ignjatovic; Fiona Newall; John Carlin; Felicia Ng; Simone Hamilton; David Ashley; Keith Waters; Paul Monagle
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

3.  Manifestations of metastatic tumors of the liver. A study of eighty-one patients subjected to needle biopsy.

Authors:  L F FENSTER; G KLATSKIN
Journal:  Am J Med       Date:  1961-08       Impact factor: 4.965

4.  Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults.

Authors:  L Bernard; F Ferrière; P Casassus; F Malas; S Lévêque; L Guillevin; O Lortholary
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

5.  C-reactive protein and erythrocyte sedimentation rate in differential diagnosis between infections and neoplastic fever in patients with solid tumours and lymphomas.

Authors:  R Kallio; A Bloigu; H M Surcel; H Syrjälä
Journal:  Support Care Cancer       Date:  2001-03       Impact factor: 3.603

6.  Fever of unexplained origin in patients with cancer.

Authors:  J Klastersky; D Weerts; C Hensgens; L Debusscher
Journal:  Eur J Cancer       Date:  1973-09       Impact factor: 9.162

7.  Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes.

Authors:  P A Pizzo; K J Robichaud; R Wesley; J R Commers
Journal:  Medicine (Baltimore)       Date:  1982-05       Impact factor: 1.889

8.  Procalcitonin in patients with and without immunosuppression and sepsis.

Authors:  B al-Nawas; P M Shah
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

9.  Identification and measurement of calcitonin precursors in serum of patients with malignant diseases.

Authors:  P P Ghillani; P Motté; F Troalen; A Jullienne; P Gardet; T Le Chevalier; P Rougier; M Schlumberger; C Bohuon; D Bellet
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

10.  Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?

Authors:  Evangelos J Giamarellos-Bourboulis; Anna Mega; Paraskevi Grecka; Nektaria Scarpa; George Koratzanis; George Thomopoulos; Helen Giamarellou
Journal:  Intensive Care Med       Date:  2002-08-07       Impact factor: 17.440

View more
  9 in total

1.  Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.

Authors:  Lidija Kitanovski; Janez Jazbec; Sergej Hojker; Metka Derganc
Journal:  Support Care Cancer       Date:  2013-09-21       Impact factor: 3.603

2.  Diagnostic Accuracy of Procalcitonin, Neutrophil-to-Lymphocyte Ratio, and C-Reactive Protein in Detection of Bacterial Infections and Prediction of Outcome in Nonneutropenic Febrile Patients with Lung Malignancy.

Authors:  Shanshan Ding; Jun Ma; Xingguo Song; Xiaohan Dong; Li Xie; Xianrang Song; Lisheng Liu
Journal:  J Oncol       Date:  2020-08-25       Impact factor: 4.375

3.  Procalcitonin as a predictive marker of infections in chemoinduced neutropenia.

Authors:  Luisa Carnino; Silvia Betteto; Maria Loiacono; Annalisa Chiappella; Alice Giacobino; Libero Ciuffreda; Patrizia Lista; Giulio Mengozzi
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-30       Impact factor: 4.553

4.  Expression of CD11b/CD18 adhesion molecules on circulating phagocytes-a novel aid to diagnose infection in patients with cancer.

Authors:  R Kallio; H Aalto; A Takala; P Ohtonen; J Collan; S Siitonen; H Joensuu; H Syrjala; H Repo
Journal:  Support Care Cancer       Date:  2008-04-15       Impact factor: 3.603

5.  Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics.

Authors:  Nicolas Penel; Jean-Pierre Delord; Marie-Edith Bonneterre; Thomas Bachelot; Isabelle Ray-Coquard; Jean-Yves Blay; Laurent Benjamin Pascal; Cécile Borel; Thomas Filleron; Antoine Adenis; Jacques Bonneterre
Journal:  Invest New Drugs       Date:  2009-02-10       Impact factor: 3.850

6.  Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia.

Authors:  Maria Hatzistilianou; Aleka Rekliti; Fanni Athanassiadou; Dorothea Catriu
Journal:  Inflamm Res       Date:  2009-10-06       Impact factor: 4.575

7.  Paraneoplastic Leukemoid Reaction in Gastroesophageal Junction Adenocarcinoma: A Case Report.

Authors:  Kevin Wei-Lun Chang; Lai Lai Kwok; Manish K Rana; Sapna Patel; Thomas Birris
Journal:  Am J Case Rep       Date:  2020-01-31

8.  Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients.

Authors:  Baykal Tulek; Habibe Koylu; Fikret Kanat; Ugur Arslan; Faruk Ozer
Journal:  Contemp Oncol (Pozn)       Date:  2013-03-15

9.  Cabozantinib as the causative agent of high-grade fever in a patient with a background of metastatic clear cell renal cell carcinoma: a case report.

Authors:  H M N Chen; M Morris; P M Manders
Journal:  J Med Case Rep       Date:  2020-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.